Advanz Challenges Janssen Patents On Schizophrenia Drug
A pharmaceuticals company has asked a court to revoke Janssen's two patents that cover how an injectable form of schizophrenia medication should be given to patients who miss a dose, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article